Authors: K. Hušek 1; P. Peťovská 2; D. Procházková 3 Authors‘ workplace: I. patologickoanatomický ústav MU, FN u sv. Anny, Brno 2Oddělení lékařské genetiky MU, FN u sv. Anny, Brno 3I. dětská interní klinika, FN Brno, pracoviště Dětská nemocnice, Brno 1 Published in: Čes.-slov. Patol., , 2003, No. 3, p. 138-142 Category:
Comparative genomic hybridisation (CGH) allows to detect genetic abnormalities associated withpoor prognosis in subset of patients with diffuse large B-cell lymphoma (DLBCL). Amplification of2p13-16 represents an adverse genetic sign especially in extranodal DLBCL. In the present case,2p13-16 amplification was revealed by CGH in extranodal DLBCL. It was localized in the mesenteryand remained resistant to the chemotherapy (CHOP). A patient, 72-year-old female, died 10weeks after the diagnosis had been made. Rapid lethal course of the disease confirms pooroutlook for patients with 2p13-16 and supports a role of CGH as a sensitive method in prognosisfor patients with DLBCL.
Key words: comparative genomic hybridization – 2p13-16 amplification – diffuse large B-cell lymphoma
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
